Softwr

Healthcare · head to head

Cerner PowerChart vs Paige

Cerner PowerChart logo

Cerner PowerChart

Healthcare

Advanced clinical charting and documentation system within Cerner EHR

From
On request
Rated
-
Paige logo

Paige

Healthcare

Digital pathology AI holding the first FDA De Novo authorisation for a pathology algorithm, now part of Tempus

From
On request
Rated
-

The short version

  • Each has a real cost: Cerner PowerChart no publicly published pricing rates available; Paige the FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • They diverge on capability: Cerner PowerChart covers Clinical Documentation, Paige covers Paige Prostate Detect.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Cerner PowerChart and Paige actually diverge.

Attributes where Cerner PowerChart and Paige differ
AttributeCerner PowerChartPaige
PlatformsWeb, DesktopWeb, Cloud, On-premise
Founded1979Unknown

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Cerner PowerChart

  • Clinical Documentation
  • Intelligent Templates
  • Evidence-Based Content
  • Clinical Decision Support
  • Workflow Automation
  • Real-time Alerts
  • HL7
  • FHIR

Only in Paige

  • Paige Prostate Detect
  • Paige Prostate Grade and Quantify
  • Perineural invasion detection
  • Breast and lymph node applications
  • FullFocus viewer
  • Foundation models
  • OmniScreen
  • Paige Alba

What people use each for

The jobs each tool is most often brought in to do.

Cerner PowerChart

  • Patient Carenot Paige
  • Medical Recordsnot Paige
  • Practice Managementnot Paige
  • Telehealthnot Paige

Paige

  • A reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffablenot Cerner PowerChart
  • A pathology department already digitised that wants a documented safety net against missed small foci of cancernot Cerner PowerChart
  • A hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reportingnot Cerner PowerChart
  • A pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variabilitynot Cerner PowerChart

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Cerner PowerChart

  • No publicly published pricing rates available

Paige

  • The FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • The algorithm is worthless without a digital pathology programme already running, and slide scanning, storage and workflow typically cost far more than the software licence.
  • Tempus acquired Paige in 2025, so the roadmap now competes for attention inside a genomics-led business, and the pathology-only buyer is no longer the primary customer.
  • Scanner compatibility is a hard constraint rather than a preference, and a laboratory with an unsupported scanner fleet cannot use the authorised indication at all.
  • Pricing is per case or per slide and unpublished, so a laboratory cannot model cost per reported case without entering a sales process.

Pricing, plan by plan

Cerner PowerChart

On request

No published plan breakdown. See the Cerner PowerChart review.

Paige

On request
  • Paige clinical applications$undefined/year
    • Priced per case or per slide analysed under annual agreement
    • Prostate, breast and other applications licensed separately
    • Requires compatible whole slide scanner and the FullFocus viewer for the authorised indication

Which should you pick?

Choose Cerner PowerChart if

  • You need clinical documentation.
  • You work on Web, Desktop.
  • You also want intelligent templates.

Choose Paige if

  • You need paige prostate detect.
  • You work on Web, Cloud, On-premise.
  • You also want paige prostate grade and quantify.

Questions people ask

Is Cerner PowerChart or Paige better?
Neither clearly leads. Cerner PowerChart starts at On request and Paige at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Cerner PowerChart or Paige?
Cerner PowerChart starts at On request and Paige at On request.
Does Cerner PowerChart or Paige run on more platforms?
Cerner PowerChart runs on Web, Desktop. Paige runs on Web, Cloud, On-premise.
What is Cerner PowerChart best used for?
Cerner PowerChart is most often used for patient care, medical records, practice management, telehealth. Of those, patient care and medical records are not what Paige is typically brought in for.
What can Cerner PowerChart do that Paige cannot?
Cerner PowerChart covers Clinical Documentation, Intelligent Templates, Evidence-Based Content, Clinical Decision Support. Paige covers Paige Prostate Detect, Paige Prostate Grade and Quantify, Perineural invasion detection, Breast and lymph node applications.

Answered from the vendors’ own pages

Cerner PowerChart: What is Cerner PowerChart pricing?

Cerner PowerChart, now part of Oracle Health, does not publish standard pricing. Enterprise healthcare EHR solutions require custom pricing based on hospital size, bed count, and module selection. Contact Oracle Health sales for quotes.

Source
Paige: What exactly is FDA authorised?

Paige Prostate Detect, as an adjunct for identifying areas of interest on digitised prostate core needle biopsy slides, viewed through the Paige FullFocus viewer on a compatible scanner. Nothing else in the portfolio holds that authorisation in the United States.

Cerner PowerChart: How do I get a demo or pricing information for Oracle Health?

Oracle Health provides a contact form and demo request option on its website. You can request a demo or contact the sales team to discuss your healthcare organization's needs and receive pricing information.

Source
Paige: Is the European position broader?

Yes. The Paige Prostate suite including grading and quantification received IVDR certification in 2025, which covers more than the United States authorisation.

Paige: What did the pivotal study measure?

Pathologist cancer detection on individual slide images improved, with reported reductions in false negative and false positive readings. It measured pathologist performance with the tool, not standalone algorithm accuracy.

Paige: Who owns Paige now?

Tempus AI acquired Paige in 2025. Products remain branded Paige.

Share

Related pages

Other head to heads